Search Results | Cancer Research | American Association for Cancer Research

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Abstract CT226: Final progression-free survival analysis of JUPITER-02, a randomized, double-blind, phase 3 study of toripalimab or placebo plus gemcitabine and cisplatin as first-line treatment for recurrent or metastatic nasopharyngeal carcinoma

Cancer Res (2022) 82 (12_Supplement): CT226.

DOI: https://doi.org/10.1158/1538-7445.AM2022-CT226

Published: 15 June 2022

View article

Journal Articles

Targeting the IRAK1–S100A9 Axis Overcomes Resistance to Paclitaxel in Nasopharyngeal Carcinoma

Lizhen Liu, Sailan Liu, Peng Deng, Yujing Liang, Rong Xiao, Lin-Quan Tang, Jinghong Chen, Qiu-Yan Chen, Peiyong Guan, Shu-Mei Yan, Xiangliang Huang, Jing Han Hong, Jianfeng Chen, Yichen Sun, Bin Tean Teh, Qiang Yu, Hai-Qiang Mai, Jing Tan

Cancer Res (2021) 81 (5): 1413–1425.

DOI: https://doi.org/10.1158/0008-5472.CAN-20-2125

Published: 01 March 2021

View article

Includes: Supplementary data

Journal Articles

De-N-acetyl GM3 Promotes Melanoma Cell Migration and Invasion through Urokinase Plasminogen Activator Receptor Signaling–Dependent MMP-2 Activation

Ji-Wei Liu, Ping Sun, Qiu Yan, Amy S. Paller, Pedram Gerami, Nancy Ho, Neelam Vashi, I. Caroline Le Poole, Xiao-qi Wang

Cancer Res (2009) 69 (22): 8662–8669.

DOI: https://doi.org/10.1158/0008-5472.CAN-09-1099

Published: 11 November 2009

View article

Journal Articles

Suppression of Epidermal Growth Factor Receptor Signaling by Protein Kinase C-α Activation Requires CD82, Caveolin-1, and Ganglioside

Xiao-qi Wang, Qiu Yan, Ping Sun, Ji-Wei Liu, Linda Go, Shauntae M. McDaniel, Amy S. Paller

Cancer Res (2007) 67 (20): 9986–9995.

DOI: https://doi.org/10.1158/0008-5472.CAN-07-1300

Published: 17 October 2007

View article

Includes: Supplementary data

Journal Articles

Inhibitory Effects of Activin on the Growth and Morphogenesis of Primary and Transformed Mammary Epithelial Cells

Qiu Yan Liu, Birunthi Niranjan, Peter Gomes, Jennifer J. Gomm, Derek Davies, R. Charles Coombes, Lakjaya Buluwela

Cancer Res (1996) 56 (5): 1155–1163.

Published: 01 March 1996

View article

NARROW

Abstract CT226: Final progression-free survival analysis of JUPITER-02, a randomized, double-blind, phase 3 study of toripalimab or placebo plus gemcitabine and cisplatin as first-line treatment for recurrent or metastatic nasopharyngeal carcinoma

Targeting the IRAK1–S100A9 Axis Overcomes Resistance to Paclitaxel in Nasopharyngeal Carcinoma

De-N-acetyl GM3 Promotes Melanoma Cell Migration and Invasion through Urokinase Plasminogen Activator Receptor Signaling–Dependent MMP-2 Activation

Suppression of Epidermal Growth Factor Receptor Signaling by Protein Kinase C-α Activation Requires CD82, Caveolin-1, and Ganglioside

Inhibitory Effects of Activin on the Growth and Morphogenesis of Primary and Transformed Mammary Epithelial Cells

Email alerts

AACR Journals

Abstract CT226: Final progression-free survival analysis of JUPITER-02, a randomized, double-blind, phase 3 study of toripalimab or placebo plus gemcitabine and cisplatin as first-line treatment for recurrent or metastatic nasopharyngeal carcinoma

Targeting the IRAK1–S100A9 Axis Overcomes Resistance to Paclitaxel in Nasopharyngeal Carcinoma

De-N-acetyl GM3 Promotes Melanoma Cell Migration and Invasion through Urokinase Plasminogen Activator Receptor Signaling–Dependent MMP-2 Activation

Suppression of Epidermal Growth Factor Receptor Signaling by Protein Kinase C-α Activation Requires CD82, Caveolin-1, and Ganglioside

Inhibitory Effects of Activin on the Growth and Morphogenesis of Primary and Transformed Mammary Epithelial Cells

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only